Rationally Designed Antibodies as Research Tools to Study the Structure–Toxicity Relationship of Amyloid-β Oligomers
Alzheimer’s disease is associated with the aggregation of the amyloid-β peptide (Aβ), resulting in the deposition of amyloid plaques in brain tissue. Recent scrutiny of the mechanisms by which Aβ aggregates induce neuronal dysfunction has highlighted the importance of the Aβ oligomers of this protei...
Main Authors: | Ryan Limbocker, Benedetta Mannini, Rodrigo Cataldi, Shianne Chhangur, Aidan K. Wright, Ryan P. Kreiser, J. Alex Albright, Sean Chia, Johnny Habchi, Pietro Sormanni, Janet R. Kumita, Francesco S. Ruggeri, Christopher M. Dobson, Fabrizio Chiti, Francesco A. Aprile, Michele Vendruscolo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/12/4542 |
Similar Items
-
Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
by: Ryan P. Kreiser, et al.
Published: (2020-11-01) -
Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
by: Ryan Limbocker, et al.
Published: (2021-06-01) -
Structural Characterization of Covalently Stabilized Human Cystatin C Oligomers
by: Magdalena Chrabąszczewska, et al.
Published: (2020-08-01) -
The elusive nature and diagnostics of misfolded Aβ oligomers.
by: Eleonora eCerasoli, et al.
Published: (2015-03-01) -
The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)
by: Barbara Mroczko, et al.
Published: (2019-09-01)